These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24291165)

  • 1. Editorial comment.
    Ploussard G
    J Urol; 2014 Mar; 191(3):637. PubMed ID: 24291165
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transrectal prostatic biopsy management policy for patients older than 50 years in relation to PSA values elaborated by a mathematical decision tree].
    Santos Arrontes D; Cortés Aránguez I; Begara Morillas F; Fernández Arjona M; de Castro Barbosa F
    Arch Esp Urol; 2005 Jun; 58(5):413-6. PubMed ID: 16078782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Serum proteomic patterns for detection of prostate cancer.
    Diamandis EP
    J Natl Cancer Inst; 2003 Mar; 95(6):489-90; author reply 490-1. PubMed ID: 12644546
    [No Abstract]   [Full Text] [Related]  

  • 4. False elevations in prostate-specific antigen levels affecting patient management.
    Kummar S; Shafi NQ
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):599-601; discussion 602. PubMed ID: 16163243
    [No Abstract]   [Full Text] [Related]  

  • 5. [PSA-screening: sensible or meaningless?].
    Dubben HH
    Urologe A; 2009 Sep; 48(9):1103; author reply 1103-4. PubMed ID: 19727645
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment.
    Epstein JI
    Urology; 2013 Jul; 82(1):152-3; discussion 153. PubMed ID: 23706589
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate detection possibility.
    Gunby P
    JAMA; 1999 Jun 23-30; 281(24):2274-5. PubMed ID: 10386541
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prostate-specific antigen for treatment monitoring].
    Graefen M; Fröhner M; Wirth M
    Urologe A; 2011 Mar; 50(3):309-12. PubMed ID: 21365346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial comment.
    Loeb S
    Urology; 2014 Mar; 83(3):596-7; discussion 597-8. PubMed ID: 24581522
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial Comment from Dr Satoh to interpreting a rising prostate-specific antigen after brachytherapy for prostate cancer.
    Satoh T
    Int J Urol; 2013 Feb; 20(2):149. PubMed ID: 22924812
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial Comment from Dr Stone to interpreting a rising prostate-specific antigen after brachytherapy for prostate cancer.
    Stone NN
    Int J Urol; 2013 Feb; 20(2):148. PubMed ID: 22924786
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment.
    Meng M
    J Urol; 2012 Jun; 187(6):2066; discussion 2066-7. PubMed ID: 22498228
    [No Abstract]   [Full Text] [Related]  

  • 13. Geographic distribution of prostate cancer incidence in the era of PSA testing, Connecticut, 1984 to 1998.
    Gregorio DI; Kulldorff M; Sheehan TJ; Samociuk H
    Urology; 2004 Jan; 63(1):78-82. PubMed ID: 14751353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate antigen. A new perception of use in serum.
    Griffiths J
    Am J Clin Pathol; 1989 Dec; 92(6):845-6. PubMed ID: 2480063
    [No Abstract]   [Full Text] [Related]  

  • 15. [Do current studies really prove the uselessness of PSA screening? : Attempt at a critical interpretation of the publicized data and the resulting echoes in the media].
    Stöckle M
    Urologe A; 2009 Aug; 48(8):912-6. PubMed ID: 19618157
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment on: Methods of calculating prostate-specific antigen velocity.
    Eggener S
    Eur Urol; 2007 Oct; 52(4):1050-1. PubMed ID: 17933029
    [No Abstract]   [Full Text] [Related]  

  • 17. [Statistical study of probabilities of rectal palpation, total PSA, and PSA density in prostate cancer].
    Ortiz Cabria R; Adriazola Semino M; Tejeda Bañez E; Alonso Villalba A; García Cobo E; Romero Rodríguez F; Monfá Bosch JM
    Arch Esp Urol; 2002; 55(1):35-40. PubMed ID: 11957749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial comment.
    Drake C
    Urology; 2013 Jun; 81(6):1302. PubMed ID: 23582480
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment.
    Türkeri L
    Can J Urol; 2010 Jun; 17(3):5169. PubMed ID: 20566008
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic challenges of clonal heterogeneity in prostate cancer.
    Haffner MC; De Marzo AM; Yegnasubramanian S; Epstein JI; Carter HB
    J Clin Oncol; 2015 Mar; 33(7):e38-40. PubMed ID: 24638011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.